ABOS icon

Acumen Pharmaceuticals

67 hedge funds and large institutions have $148M invested in Acumen Pharmaceuticals in 2023 Q4 according to their latest regulatory filings, with 20 funds opening new positions, 28 increasing their positions, 9 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding

Funds holding:

less ownership

Funds ownership:

18% less capital invested

Capital invested by funds: $179M → $148M (-$31.5M)

50% less funds holding in top 10

Funds holding in top 10: 21 (-1)

82% less call options, than puts

Call options by funds: $810K | Put options by funds: $4.57M

Holders
67
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$810K
Puts
$4.57M
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
1
$57.3M
2
$13.1M
3
$12.9M
4
$8.83M
5
$7.28M
6
$7.06M
7
$6.25M
8
$5.74M
9
$2.82M
10
$2.32M
11
$2.32M
12
$2.17M
13
$2.16M
14
$1.92M
15
$1.84M
16
$1.21M
17
$1.02M
18
$953K
19
$948K
20
$939K
21
$568K
22
$555K
23
$530K
24
$503K
25
$498K